Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / September 17, 2020 / Sadeh LLP, a global investor rights law firm, is investigating: Akcea Therapeutics, Inc. (NASDAQ:AKCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Io...
NEW YORK, NY / ACCESSWIRE / September 12, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Aimmune Therapeutics, Inc. (NASDAQ:AIMT) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its...
NEW YORK , Sept. 10, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating: Principia Biopharma Inc. (NASDAQ: PRNB) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties r...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Stocks avoided back-to-back blowout losses Friday but couldn't quite close out the week with a gain, as a late-afternoon rally fell shor...
NEW YORK, NY / ACCESSWIRE / September 3, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Akcea Therapeutics, Inc. (NASDAQ:AKCA) to Ionis Pharmaceuticals, Inc. is fair to Akcea shareholders. Under the terms of the agreement, Ionis will acquire ...
Ionis Pharmaceuticals ( IONS +1.3% ) is slightly ahead of the broad market advance following its update on its cardio-renal franchise. Highlights: More news on: Ionis Pharmaceuticals, Inc., Akcea Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Gainers: Aimmune Therapeutics (NASDAQ: AIMT ) +171% . More news on: Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., Genworth Financial, Inc., Stocks on the move, Read more ...
BOSTON, MA / ACCESSWIRE / August 31, 2020 / Block & Leviton LLP ( www.blockleviton.com ), a national securities litigation firm, has opened an investigation into the proposed acquisition involving Akcea Therapeutics, Inc. (NASDAQ:AKCA). In this proposed acquisition, Akcea's controlling s...
Akcea Therapeutics (NASDAQ: AKCA ) , a majority-owned affiliate of Ionis Pharmaceuticals (NASDAQ: IONS ) presents data from the Phase 2 clinical trial of vupanorsen (AKCEA-ANGPTL3-L Rx ) at the ESC Congress 2020. More news on: Akcea Therapeutics, Inc., Ionis Pharmaceuticals, I...
Aimmune Therapeutics (NASDAQ: AIMT ) +171% on being acquired by Nestle. More news on: Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., Genworth Financial, Inc., , , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Akcea Therapeutics Inc. Company Name:
AKCA Stock Symbol:
NASDAQ Market:
Akcea Therapeutics Inc. Website:
Ionis and Akcea win prestigious Prix Galien Award for TEGSEDI® (inotersen) as Best Biotechnology Product PR Newswire BOSTON and CARLSBAD, Calif., Oct. 30, 2020 BOSTON and CARLSBAD, Calif. , Oct. 30, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, In...
Ionis Pharmaceuticals completes acquisition of Akcea Therapeutics Transaction creates a stronger, more efficient company PR Newswire CARLSBAD, Calif., Oct. 12, 2020 CARLSBAD, Calif. , Oct. 12, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS...
NEW YORK, NY / ACCESSWIRE / September 23, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Akcea Therapeutics, Inc. (NASDAQ: AKCA ), relating...